Correlation Between Milestone Pharmaceuticals and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Pasithea Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and Pasithea Therapeutics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Milestone and Pasithea is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Pasithea Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.49 times more return on investment than Pasithea Therapeutics. However, Milestone Pharmaceuticals is 2.04 times less risky than Pasithea Therapeutics. It trades about 0.28 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.3 per unit of risk. If you would invest 144.00 in Milestone Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 40.00 from holding Milestone Pharmaceuticals or generate 27.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 50.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Pasithea Therapeutics |
Milestone Pharmaceuticals and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Pasithea Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.The idea behind Milestone Pharmaceuticals and Pasithea Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. HCW Biologics | Pasithea Therapeutics vs. Scpharmaceuticals | Pasithea Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |